Published in Recenti Prog Med on November 21, 1995
Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology (2003) 1.94
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology (2010) 1.85
Overview of azathioprine treatment in multiple sclerosis. Lancet (1991) 1.83
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology (2008) 1.63
Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain (2003) 1.60
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (2001) 1.51
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain (2007) 1.48
Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr (2000) 1.46
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology (2010) 1.44
The role of 3D and speckle tracking echocardiography in cardiac amyloidosis: a case report. Eur Rev Med Pharmacol Sci (2014) 1.37
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry (1999) 1.21
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology (2004) 1.20
Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler (2011) 1.20
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain (2001) 1.17
Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult Scler (2009) 1.13
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study. Mult Scler (2013) 1.12
Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study. Neurol Sci (2011) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. Ann Neurol (2009) 1.09
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Cognitive impairment and structural brain damage in benign multiple sclerosis. Neurology (2008) 1.06
Evaluation of evoked potentials and lymphocyte subsets as possible markers of multiple sclerosis: one year follow up of 30 patients. J Neurol Neurosurg Psychiatry (1986) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology (2011) 1.04
Devic's neuromyelitis optica: clinical features and prognostic factors. Neurol Sci (2004) 1.03
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain (2006) 1.02
Refractory Takayasu arteritis successfully treated with infliximab. Eur Rev Med Pharmacol Sci (2009) 1.00
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99
The role of lymphocyte subset analysis in defining the clinical evolution of multiple sclerosis. Eur Neurol (1987) 0.98
Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98
MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology (1999) 0.98
Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97
Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica. Neurology (2004) 0.95
Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2013) 0.95
Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy. Phys Rev Lett (2012) 0.95
Graft-tunnel mismatch in endoscopic anterior cruciate ligament reconstruction. Intraoperative and cadaver measurement of the intra-articular graft length and the length of the patellar tendon. Knee Surg Sports Traumatol Arthrosc (1998) 0.93
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology (2012) 0.93
Pharmacokinetics of ceforanide. Antimicrob Agents Chemother (1982) 0.93
Peripheral neuropathy associated with ischemic vascular disease of the lower limbs. Angiology (1996) 0.93
Complement activation in hypercholesterolemia. Nutr Metab Cardiovasc Dis (2000) 0.92
Arthroscopic assisted bone grafting for early stages of Kienböck's disease. Hand Surg (2011) 0.92
MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. J Neurol (2006) 0.91
CREB regulation of BK channel gene expression underlies rapid drug tolerance. Genes Brain Behav (2009) 0.91
Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin Exp Immunol (2008) 0.91
Correlations between structural CNS damage and functional MRI changes in primary progressive MS. Neuroimage (2002) 0.91
First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution. Neurology (2005) 0.90
Search for supersymmetry in pp collisions at √7 TeV in events with two photons and missing transverse energy. Phys Rev Lett (2011) 0.90
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients. J Neurol (2012) 0.89
Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes. Clin Exp Med (2006) 0.89
Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study. Int J Immunopathol Pharmacol (2011) 0.89
Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort. Eur J Neurol (2010) 0.89
Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects. Int J Cardiol (2004) 0.89
Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis. Mult Scler (2011) 0.89
Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI. Neurology (2006) 0.88
Behaviour of von Willebrand factor antigen in follow-up of polymyalgia rheumatica/giant cell arteritis. Scand J Rheumatol (1988) 0.88
The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis. Mult Scler (2009) 0.88
Chronic urticaria and blastocystis hominis infection: a case report. Eur Rev Med Pharmacol Sci (2004) 0.87
Pharmacokinetics of cefadroxil after oral administration in humans. Antimicrob Agents Chemother (1982) 0.87
Measurement of the B(+) production cross section in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2011) 0.86
Search for pair production of second-generation scalar leptoquarks in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.86
Structural and functional abnormality of systemic microvessels in cardiac syndrome X. Nutr Metab Cardiovasc Dis (2005) 0.86
Measurement of the B0 production cross section in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2011) 0.85
Search for three-jet resonances in pp collisions at square root(s)=7 TeV. Phys Rev Lett (2011) 0.85
Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study. J Clin Endocrinol Metab (2001) 0.85
Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry (2011) 0.85
Pharmacokinetics and pharmacodynamics of neutrophil-associated ciprofloxacin in humans. Clin Pharmacol Ther (1995) 0.84
Observation of sequential Υ suppression in PbPb collisions. Phys Rev Lett (2012) 0.84
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment. J Neurol Sci (2009) 0.84
An unusual case with relapsing neuromyelitis optica associated with undifferentiated connective tissue disease. Neurol Sci (2004) 0.83
Italian version of the Chicago multiscale depression inventory: translation, adaptation and testing in people with multiple sclerosis. Neurol Sci (2004) 0.83
Absence of diffuse cervical cord tissue damage in early, non-disabling relapsing-remitting MS: a preliminary study. Mult Scler (2008) 0.83
A short introduction to pharmacokinetics. Eur Rev Med Pharmacol Sci (2003) 0.83
Evidence for widespread movement-associated functional MRI changes in patients with PPMS. Neurology (2002) 0.83
Preclinical hypogonadism in genetic hemochromatosis in the early stage of the disease: evidence of hypothalamic dysfunction. J Endocrinol Invest (1992) 0.82
Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses. Neurology (2002) 0.82
Disclosing the diagnosis of multiple sclerosis: the Profile Project. J Neurol (2012) 0.82
[Effectiveness and tolerability of heparan sulfate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide]. Minerva Cardioangiol (1997) 0.82
Cardiac dysautonomia and serotonin plasma levels in Rett syndrome. Neuropediatrics (2004) 0.82
Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee. Int J Clin Pharmacol Res (1994) 0.82
Psychosocial issue in children and adolescents with multiple sclerosis. Neurol Sci (2010) 0.82
Cord damage elicits brain functional reorganization after a single episode of myelitis. Neurology (2003) 0.81
Study of Z Boson Production in PbPb Collisions at √S(NN)=2.76 TeV. Phys Rev Lett (2011) 0.81
A longitudinal conventional and magnetization transfer magnetic resonance imaging study of optic neuritis. Mult Scler (2007) 0.81
Pregnancy: a factor influencing the course of multiple sclerosis? Eur Neurol (1981) 0.81
Genetic influence in statin intolerance. Clin Pharmacol Ther (2011) 0.81
Systemic adenosine increase during cold pressor test is dependent on sympathetic activation. Clin Exp Pharmacol Physiol (1999) 0.81
Effect of hydrogen peroxide on antioxidant enzymes and metallothionein level in the digestive gland of Mytilus galloprovincialis. cavalett@unipmn.it. Comp Biochem Physiol C Toxicol Pharmacol (2002) 0.80
D-penicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis. Rheumatol Int (1995) 0.80
Monoclonal antibody analysis of blood T-cell subsets in multiple sclerosis. Ital J Neurol Sci (1984) 0.80